Literature DB >> 28439948

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.

Sadanori Furudate1, Taku Fujimura1, Yumi Kambayashi1, Takanori Hidaka1, Yota Sato1, Kayo Tanita1, Akira Hashimoto1, Setsuya Aiba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28439948     DOI： 10.1111/1346-8138.13898

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  2 in total

Review 1.  Melanoma and Immune Checkpoint Inhibitors.

Authors:  Masutaka Furue; Takamichi Ito; Naoko Wada; Maiko Wada; Takafumi Kadono; Hiroshi Uchi
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

Review 2.  Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside.

Authors:  Taku Fujimura; Yasuhiro Fujisawa; Yumi Kambayashi; Setsuya Aiba
Journal:  Cancers (Basel)       Date:  2019-09-11       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.